Jug-PLGA-NPs, a New Form of Juglone with Enhanced Efficiency and Reduced Toxicity on Melanoma

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes

Yih-Cherng Liou, Akihide Ryo, Han-kuei Huang et al. · Proceedings of the National Academy of Sciences · 2002 · 340 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription

Shiou-Huei Chao · Nucleic Acids Research · 2001 · 159 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling

Flore Kruiswijk, Sebastian C. Hasenfuss, Renuka Sivapatham et al. · Oncogene · 2015 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +17

Synthesis, characterization and antibacterial activity of juglone encapsulated<scp>PLGA</scp>nanoparticles

Tülin Arasoğlu, Serap Derman, Banu Mansuroğlu et al. · Journal of Applied Microbiology · 2017 · 54 citations

Pharmacy, Bioengineering, Pharmaceutics +17